Company Update Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Zydus and Lupin sign licensing agreement for co-marketing of Saroglitazar Mg, a critical treatment for chronic liver diseases in India.